Guggenheim Capital LLC Senseonics Holdings, Inc. Transaction History

Guggenheim Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$0.68 - $1.25 $7,977 - $14,665	11,732 New	11,732 $8,000
Q2 2022 Aug 15, 2022	SELL	$0.94 - $1.94 $132 - $273	-141 Reduced 1.19%	11,732 $12,000
Q1 2022 May 16, 2022	BUY	$1.54 - $3.71 $18,284 - $44,048	11,873 New	11,873 $23,000
Q2 2018 Aug 14, 2018	SELL	$3.03 - $4.98 $46,355 - $76,189	-15,299 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.48 - $3.21 $230 - $298	93 Added 0.61%	15,299 $46,000
Q4 2017 Feb 14, 2018	SELL	$2.43 - $3.54 $4,614 - $6,722	-1,899 Reduced 11.1%	15,206 $40,000
Q3 2017 Nov 14, 2017	BUY	$2.22 - $3.2 $37,973 - $54,736	17,105	17,105 $55,000

137

60M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $526M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.